Spectroscopic Studies of the Electron Donor-Acceptor Interaction of Chloroquine Phosphate with Chloranilic Acid by Ofokansi, KC et al.
Adisa et al 
Trop J Pharm Res, February 2009; 8 (1): 87 
Tropical Journal of Pharmaceutical Research, February 2009; 8 (1): 87-94 
© Pharmacotherapy Group,  
Faculty of Pharmacy, University of Benin,  
Benin City, 300001 Nigeria.  
All rights reserved. 
 




Spectroscopic Studies of the Electron Donor-Acceptor 
Interaction of Chloroquine Phosphate with Chloranilic 
Acid 
 
KC Ofokansi1*, EO Omeje2, and CO Emeneka1  
1
Department of Pharmaceutics, 
2
Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmaceutical 





Purpose: The electron donor-acceptor interaction between drugs which act as electron donors and 
some electron-deficient compounds (π acceptors) has severally been utilized as an analytical tool for 
the quantitation and qualitative assessment of such drugs. The objective of this study, therefore, was to 
develop an assay procedure for dosage forms of chloroquine phosphate based on its reaction with 
chloranilic acid which resulted in the formation of a charge-transfer complex. 
Methods: The complex formation between chloroquine phosphate and chloranilc acid as evidenced by 
the instantaneous change in colour of a solution of chloranilic acid in dioxan from yellow to purple upon 
addition of a solution of chloroquine phosphate in chloroform was monitored spectrophotometrically to 
determine the wavelength of maximum absorption. The stoichiometry of the complex formed was 
evaluated using the Job’s continuous variation method while the thermodynamics of the complex was 
evaluated spectrophotometrically with the aid of the Benesi-Hildebrand plot. 
Results: Spectrophotometric absorption studies showed evidence of the formation of strongly bonded 
and highly stable charge-transfer complex between chloroquine phosphate and chloranilic acid in a 3:2 
stoichiometry in non-aqueous medium. The transitions involved were detected at wavelengths longer 
than those of the individual pure substances in the visible region of the spectrum. Conformity with Beer’s 
law was evident over the concentration range 0.8 – 8.0 mg/100 ml
 
of chloroquine phosphate; thus 
making  it possible for an accurate quantitative determination of the drug.  
Conclusion: The studied complexation phenomenon formed a basis for the quantitative determination 
of both pure samples and individual dose units of chloroquine phosphate and is considered a simple, 
sensitive and precise analytical tool with high accuracy for routine analysis of chloroquine phosphate in 
developing countries where sophisticated analytical instruments may not be available. 
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Chloroquine phosphate, a synthetic 4 – 
aminoquinoline antimalarial is designated 





-diethyl phosphate) and 
occurs as a 1:2 salt. Chloroquine has 
remained highly effective against erythrocytic 
forms of P. vivax, P. ovale, P. malaria and the 
sensitive strains of P. falciparum over the 
years in tropical climates all over the world. It 
is also used in the treatment of amebiasis, 
rheumatoid arthritis, discoid lupus 
erythematosus and photosensitive diseases. 
In recent times, the antimalarial potential of 
this commonly available and affordable drug 
has been threatened with the upsurge in 
resistant plasmodium strains occasioned by 
the influx and use of sub-optimal doses of 
chloroquine phosphate imported by dubious 
business merchants in sub-Saharan Africa
1
. 
The economic importance of this development 
could best be imagined at both national and 
global levels. As a result, developing nations 
largely in response to current World Health 
Organisation (WHO) recommendation, have 
begun to develop new antimalarial policies 
revolving around atermisinin based 
combination therapy
2
. While WHO’s 
recommendation has gained much support 
based on available data, it is believed in 
several quarters that the observed upsurge in 
resistance to chloroquine therapy could be 
partly traced to circulation of poor quality 
chloroquine dosage forms in the chaotic drug 
distribution system especially in Nigeria. In 
some instances, the active chloroquine 
content is grossly sub-optimal. The assay of 
chloroquine phosphate and other antimalarials 
in the drug market to ascertain their quality 
and suitability for use has, therefore, become 
a necessity.   
 
Analytical methods based on non-aqueous 
thermometric titration and HPLC have been 
reported for the assay of chloroquine 
phosphate
3,4
. HPLC-based analytical tools are 
usually not available in most developing 
countries in Africa including Nigeria and hence 
the need to search for simpler and yet 
sensitive alternative analytical procedures.  
 
Charge transfer complex formation results 
from a donor-acceptor mechanism of Lewis 
base-acid reaction between two or more 
different chemical constituents, preferably 
aromatic nucleus–based compounds with 
electron–rich centers and electron-deficient 
compounds. The formation of electron-donor-
acceptor (EDA) complexes can be rapidly 
assessed for its validity as a simple 
quantitative analytical method for many drug 
substances, which could act as electron 
donors because of their possession of one or 
more electron-rich (basic) centres. Chloranilic 
acid and other π-acceptors have been 
variously utilized in the spectrophotometric 
assay and analysis of many drug substances 
which could act as electron donors
5-10
. The 
thermodynamic studies of some of these 
complexes resulting from electron donor-





Given the electron-rich structure of 
chloroquine, the formation of a stable charge-
transfer complex with chloranilic acid was 
exploited for the quantitative determination of 
chloroquine via spectrophotometry. The above 
background provided a motivation for this 
study. Besides, to the best of our knowledge, 
there is so far no documented report on the 
thermodynamic studies of the charge–transfer 
interaction between chloroquine and any 
known π-acceptors. The present study 
describes a simple, sensitive and precise 
assay procedure for chloroquine phosphate in 
pure powder and in various dosage forms 
which could easily be adapted for use in most 
developing countries in sub-Saharan Africa. 
The stoichiometric balance as well as the 
thermodynamics of this EDA interaction are 
also presented.     
 




Chloroquine phosphate, pure powder 
(Shangai Pharmaceuticals, China) Maladrin
®
 
tablet, (PZ Pharmaceuticals Ltd., Nigeria), 
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generic chloroquine phosphate tablets (Emzor 
Pharm. Ind. Ltd., Nigeria). Quivaclor
®
 injection 
(Right Angle Pharmaceuticals, Nigeria); 
chloranilic acid (Merck, Germany); 1, 4-
dioxan, sodium hydroxide and chloroform 
(May and Baker, England), were used. Other 
solvents and reagents were of analytical 
grade and used without further purification. All 
laboratory reagents were freshly prepared.       
 
Preparation of standard solutions  
 
Amounts of chloroquine phosphate pure 
powder equivalent to 20 mg and 40 mg 
chloroquine base respectively were accurately 
weighed in an analytical balance (Metler 
Toledo) and transferred into two separate 250 
ml separating funnels containing 10 ml of 
water. The solutions were made alkaline with 
3 ml of 2 M sodium hydroxide and shaken 
successively for 2 min with 15 and three 10 ml 
portions of chloroform. Each chloroform 
extract was washed with 15 ml of water in a 
different separating funnel. The washed 
chloroform extracts were pooled and each 
passed through 2 g of anhydrous sodium 
sulphate supported on a filter paper in a small 
funnel into separate 50 ml volumetric flasks 
and made up to volume with chloroform to 
afford standard solutions of 1.25 x 10
-3
 M and 
2.5 x 10
-3
 M chloroquine base respectively. 
For chloranilic acid, two separate quantities 
were accurately weighed in an analytical 
balance and quantitatively transferred into a 
clean dry 50 ml volumetric flask. The powders 
were dissolved in 1, 4 dioxan and made up to 
volume to give standard solutions of 2.5 x10
-3 
M and 1.8 x10
-2
 M.  
 
Assay procedure for the tablets  
 
An amount of pulverized chloroquine 
phosphate tablets equivalent to 40 mg of 
chloroquine base was accurately weighed. 
This was dissolved in about 10 ml of water in 
a beaker and filtered to remove the excipients. 
The resulting filtrate was quantitatively 
transferred to a 250 ml separating funnel and 
then treated exactly as described under 
preparation of standard solutions. Four 
replicate experiments were carried out in each 
case. 
Assay procedure for the injection  
 
A volume of injection equivalent to 20 mg 
chloroquine base (0.5 ml) was transferred into 
a 250 ml separating funnel containing 10 ml of 
water and treated exactly as described under 
preparation of standard solutions. 
 
Absorption spectra  
 
A solution of chloranilic acid (2.5 x 10
-3 
M) was 
made in 1,4 dioxan and its wavelength of 
maximum absorption was determined by 
scanning through a series of wavelengths in 
the visible region of the spectrum using a Uv-
Vis double beam spectrophotometer (SP-8 
100, Pye-Unicam). A colour was developed by 
mixing 2 ml of chloranilic acid solution (2.5x10
-
3
 M) with 2 ml of chloroquine solution (2.5x10
-3
 
M) and the wavelength of maximum 
absorption for the resulting solution was then 
determined. 
 
Standard curve  
 
For calibration, serial volumes of 0.1 to 1.0 ml 
in 0.1 ml steps of 1.25x10
-3
 M concentration of 
chloroquine base in chloroform (pure sample) 
were transferred to different test tubes, and 
each mixed with 2.5 ml of 2.5x10
-3 
M 
concentration of chloranilic acid in dioxan. The 
volumes were made up to 5 ml with 
chloroform. Their absorbance were measured 
at 520 nm against a blank prepared 
simultaneously without chloroquine base 
solution.    
 
Stoichiometric relationship  
 
The stoichiometry of the donor and the 
acceptor in the complex was determined by 
the Job’s method of continuous variation
11
. 
Master solutions of equimolar concentrations 
(2.5x10
-3
 M) of chloroquine base in chloroform 
and chloranilic acid in dioxan were prepared. 
A series of 5 ml quantities of the master 
solutions comprising complementary 
proportions of the two solutions (0.5:4.5, 
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1.0:4.0, …, 4.5:0.5) were transferred to 
different test tubes and the complex formed 
for each reaction mixture was allowed to stand 
for 30 min at room temperature before 
absorption measurement at 520 nm against a 
blank prepared from a mixture of dioxan and 
chloroform.  
 
Association constant, molar absorptivity 
and free energy change 
 
The association constant and molar 
absorptivity of the complex were estimated 
using the Benesi-Hildebrand plot
12
. Serial 
volumes of 0.1-1.0 ml of 2.5x10
-3
 M 
concentration of chloroquine base in 
chloroform in 0.1 ml steps were transferred to 
different test tubes. The volumes were diluted 
to 3 ml with chloroform and 2 ml of a 1.8x10
-2
 
M solution of chloranilic acid in dioxan was 
added. The contents were mixed gently and 
the whole set of test tubes were subjected to a 
temperature of 35 
o
C for 10 min in a 
thermostated water bath. Following the same 
procedure, three other sets of test tubes 
containing identical solutions as the first set 
were prepared and each set subjected to 
temperatures of 45, 55 and 65 °C 
respectively. The procedure was continued as 





There was an instantaneous change to a 
purple colour from the yellowish pink colour of 
chloranilic acid in dioxan upon reaction with 
chloroquine. This colour change was 
indicative of charge transfer complex 
formation between chloroquine acting as the 
n-donor and chloranilic acid acting as the π-
acceptor. Chloranilic acid in a solution of 
dioxan displayed an absorption peak at 430 
nm while a new absorption band at 520 nm 
was established for the complex as shown in 
Fig. 1. Although the complex formation was 
instantaneous, constant absorbance readings 
were obtained after 30 min at room 
temperature (30 °C) and these remained 
constant for two additional hours (data not 
shown). The purple colour of the complex was 
retained even after 48 h of storage in the dark 
but with marked reduction in the absorbance 
values. The determination of the mole ratio of 
reactants in the complex was based on the 
continuous variation plot as proposed by Job. 
The Job’s plot is depicted in Fig. 2 and shows 
a 3:2 complexation ratio between the donor 
and the acceptor. The thermodynamic 
parameters as evaluated for the complex, 
from the Benesi-Hildebrand plot, are shown in 
Table 1. The high values of the association 
constant even at high temperatures was an 
indication of the stability of the complex. The 
general trend, however, was that the 
association constants decreased 
progressively with increase in temperature. 
Increase in temperature may have resulted in 
a gradual but steady dissociation of the 




The bathochromic shift as shown in Fig. 1 was 
a further indication of the formation of a 
complex.  The interaction between 
chloroquine (CQ) and chloranilic acid (CA) is a 
charge transfer complexation reaction 
followed by the formation of radical anion 
according to the scheme below: 
 
             ••                •• 
   CQ + CA ↔ [CQ-CA] (outer complex) 
 
                                 ••                   




] (inner complex) 
                                                                                                                      
The 3:2 stoichiometry obtained from the 
continuous variation plot is an indication that 
three molecules of the donor required two 
molecules of the acceptor for complexation 
thus:  
  
3CQ + 2CA = [3CQ−2CA]                   (1) 
 
This observed stoichiometry was anticipated 
because of the presence of more than one 
electron-donating (nucleophilic) centres in the 
molecular structure of chloroquine. It is 
probable also that there is a presence of 
multiple binding sites for chloranilic acid in the  
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Fig 1: Absorption spectra of chloranilic acid and EDA complex 




Fig. 2: Continuous variation plot of chloranilic acid-chloroquine complex 
 




K)  Kc ( mol
-1
)      ε (mol l
-1


















308               155.78               324.21             ‒12915.91                                                      41.88               
318               125.39                346.52             ‒12787.23                    ‒17.33                      40.16               
328               103.15               370.53             ‒12624.09                                                      38.44             
338               85.33                 399.22             ‒12491.20                                                      36.90              
Kc = association constant; ε = molar absorptivity; ∆G
O
  = free energy change; ∆H
O
  = enthalpy change; ∆S
O
  
= entropy change. 
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molecular structure of chloroquine. The 
absorbance of the complex obtained 
experimentally was used to calculate the 
molar absorptivities and association constants 
using the Benesi–Hildebrand equation which 
depends on the experimental condition that 
one of the two component species should be 
present in large excess, so that its 
concentration is virtually unaltered on 
formation of the complex. Mathematically, the 
Benesi- Hildebrand equation is represented 
as:  
 
 [A0]/A = 1/K[D0]. ε + 1/ε                       (2)           
 
Where K is the association constant, A is the 
absorbance and ε is the molar extinction 
coefficient or molar absorptivity of the 
complex. [AO] and [DO] are the initial 
concentrations of the acceptor and donor 
respectively. The ε values were obtained from 
the inverse of the intercepts of the Benesi – 
Hildebrand plot at various temperatures while 
the association constants were obtained from 
the slope of the same plot as shown in Fig. 3. 
The thermodynamic parameters were 
calculated from the following well known 
equation:   
 
Log K =  -∆H
0
/2.303RT + C                    (3) 
 
 A plot of log K
 
against the reciprocal of the 
absolute temperature, I/T (as shown in the 
inset in Fig. 3) should afford a linear slope of – 
∆H
O
/2.303R, from which ∆H
O
 could be 





does not depend on the 
temperature. R is the molar gas constant and 
T is the temperature in degree Kelvin. The 
Gibb’s free energy changes of the reaction, 
∆G°, at different temperatures were evaluated 
from the relation: 
 
∆G° = -RTlnK = -2.303RT log K            (4)   
 
while the entropy, ∆S°, of the reaction at 
different temperatures was related to the free 
energy change and enthalpy change and 












Fig. 3: Benesi-Hildebrand plot of chloranilic acid-chloroquine complex. The inset shows the plot of log K 
versus 1/T for the interaction and its slope is calculated to be 0.9048 
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The thermodynamic parameters of the formed 
complex are presented in Table 1. The molar 
absorptivities were found to be fairly constant 
at different temperatures; a confirmation of the 
independence of molar absorptivity on 
temperature. Although molar absorptivity of 
any complexing species should ideally be 
independent of temperature, empirically this is 
not always the case; hence the slight 
variations observed in this study. The values 
recorded in Table 1 are averages calculated 
from the curves at different temperatures. The 
association constant as seen in Table 1 
decreased progressively with increasing 
temperature. Increase in temperature may 
have resulted in a gradual but steady 
dissociation of the formed chloranilic acid-
chloroquine complex. This seems to follow a 
known trend for complexation reactions. A 
negative free energy change (∆G
O
) is 
indicative of a spontaneous reaction. The 
complex formation between chloranilic acid 
and chloroquine occurred spontaneously. The 
high association constants are further pointers 
to the stability of the charge transfer complex 
formed between chloranilic acid and 
chloroquine.  
 
The standard calibration graph for chloroquine 
was constructed by plotting absorbance 
versus concentration (mg/100 ml
 
) calculated 
after addition of the chloranilic acid solution. 
Conformity with Beer’s law was evident in the 
concentration range 0.8 – 8 mg/100 ml
 
 of 
chloroquine base. The derived regression 
equation of the line using the method of least 
squares is: 
 






         (6)   
 
for which the correlation coefficient is 0.998. 
A520 is the absorbance at 520 nm and C is the 
concentration of chloroquine expressed in 
mg/100 ml. Deviations from linearity in Beer’s 
plot was observed when the concentrations of 
donor and acceptor differed in magnitude. 
This has been attributed to formation of 
termolecular or higher complexes
7
. For this 
reason, the concentration of the acceptor was 
kept slightly higher than, but at the same order 
of magnitude as, that of the donor. The validity 
of the regression equation was assessed in 
the determination of chloroquine in different 
dosage forms. Table 2 shows the accuracy of 
the developed method. There were generally 
high quantitative recoveries with acceptable 
standard deviations. The performance of the 
proposed method was judged through 
calculation of the Student’s t-test. At α = 0.05, 
the calculated value of t did not exceed the 
theoretical value; indicating that the proposed 
method yielded assay results not significantly 
different from the true values according to 
label claims. These values are in agreement 
with label claims of the different brands and 
further lend credence to the high accuracy of 
the method as it yielded assay results within 




Table 2: Assay results for chloroquine phosphate in pure sample and in dosage forms using the 
proposed method 
 
Parameter                                Pure sample                           Dosage form 
                                                                                    A                     B                   C 
Mean recovery(%)                      98.91                    97.72               99.91             98.89 
Standard deviation (%)                1.41                      1.30                 1.08              1.47  
Calculated value of t
*
                    1.25                     0.76                 0.60              1.31 
Correlation coefficient (r)           0.998                    0.996                0.999             0.997                   
*
The value for t-theoretical at α = 0.05 is 2.015; n=4 for each dosage form and for pure sample  
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CONCLUSION 
 
This study has yielded a sensitive assay 
procedure, based on the charge-transfer 
complexation phenomenon for the quantitative 
determination of chloroquine in pure samples 
and in various dosage forms. In addition to its 
high sensitivity and precision, this method of 
analysis based on EDA interaction is simpler, 
faster, as sensitive but cheaper than most 
official methods already reported for the assay 
of chloroquine. The proposed method is, 
therefore, suitable for the analysis of 
chloroquine in pure samples and in dosage 
form especially in developing nations where 
critical and constant evaluation of drug 
substances has become increasingly 
important on account of the high incidence of 
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